Search | IOVS | ARVO Journals

Showing 1 – 20 of 34

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Visual field score decline in eyes with untreated diabetic retinopathy: historical data from the Diabetic Retinopathy Study (DRS) randomized clinical trial

Susan Vitale; Debora Lee; Elvira Agron; Tiarnan D L Keenan; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):564 – A0129. doi:

ARVO Annual Meeting Abstract June 2022

Anti-drug antibodies to monoclonal TNF inhibitors in non-infectious uveitis

Matthew McHarg; Sunil Bellur; Wijak Kongwattananon; Susan Vitale; H Nida Sen; Shilpa Kodati

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):3194 – A0420. doi:

ARVO Annual Meeting Abstract June 2021

Does cataract surgery increase the risk of future development of late AMD? A nested case-control study from the AREDS2 and AREDS2 Follow-On studies

Susan Vitale; Elvira Agron; Sanjeeb Bhandari; David Peprah; Maureen C Farrell; Traci E Clemons; Tiarnan D L Keenan; Amitha Domalpally; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):174. doi:

ARVO Annual Meeting Abstract June 2021

Cataract Surgery and the Risk of Progression to Late Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2

SANJEEB BHANDARI; Elvira Agron; Susan Vitale; David Peprah; Maureen Farrell; Traci E Clemons; Tiarnan D L Keenan; Amitha Domalpally; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2944. doi:

ARVO Annual Meeting Abstract June 2020

Predictors of poor visual acuity 2 years after initial anti-VEGF therapy in the Age-Related Eye Disease Study 2 (AREDS2)

Susan Vitale; Chinwenwa Okeagu; Elvira Agron; Tiarnan D L Keenan; Traci E Clemons; Amitha Domalpally; Emily Chew

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4173. doi:

ARVO Annual Meeting Abstract June 2020

Hierarchical Cluster Analysis of Serum and Vitreous Cytokines in Intermediate, Posterior and Panuveitis

David Dao; Sonny Caplash; Sapna Gangaputra; pradeep dagur; Susan Vitale; Douglas A Jabs; MUST Research Group; J. Philip McCoy; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3655. doi:

Articles November 2019

Repeatability of Optical Coherence Tomography Angiography in Uveitic Eyes

PDF

Sonny Caplash; Shilpa Kodati; Shuk Kei Cheng; Marib Akanda; Susan Vitale; Ian Thompson; Sapna Gangaputra; H. Nida Sen
TAGS: angiogram, chief complaint, eye, fluid flow, optical coherence tomography, uveitis, artifacts, cohort studies
Trans. Vis. Sci. Tech.. 2019; 8(6):17. doi: https://doi.org/10.1167/tvst.8.6.17

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

Susan Vitale; Elvira Agron; Traci E Clemons; Amitha Domalpally; Ronald P Danis; Tiarnan D L Keenan; Emily Y Chew

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):52. doi:

Special Issue February 2019

IMI – Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies

PDF

Daniel Ian Flitcroft; Mingguang He; Jost B. Jonas; Monica Jong; Kovin Naidoo; Kyoko Ohno-Matsui; Jugnoo Rahi; Serge Resnikoff; Susan Vitale; Lawrence Yannuzzi
TAGS: myopia
Invest. Ophthalmol. Vis. Sci.. 2019; 60(3):M20-M30. doi: https://doi.org/10.1167/iovs.18-25957

ARVO Annual Meeting Abstract July 2018

Assessing the Variability and Repeatability of OCT-A in Uveitis Patients

Sonny Caplash; Shuk Kei Cheng; Marib Akanda; Shilpa Kodati; Susan Vitale; Ian Thompson; Benjamin Chaon; Hatice Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1534. doi:

ARVO Annual Meeting Abstract July 2018

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Susan Vitale; Elvira Agron; Tiarnan Keenan; Traci E Clemons; Emily Y. Chew

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6013. doi:

Retina April 2018

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity

PDF

Ali M. Allahdina; Paul F. Stetson; Susan Vitale; Wai T. Wong; Emily Y. Chew; Fredrick L. Ferris III; Paul A. Sieving; Catherine Cukras

Invest. Ophthalmol. Vis. Sci.. 2018; 59(5):1953-1963. doi: https://doi.org/10.1167/iovs.17-22668

ARVO Annual Meeting Abstract June 2017

Assessing the prognostic significance of early changes in AMD scale score in the AREDS study

Susan Vitale; Elvira Agron; Traci E Clemons; Amitha Domalpally; Ronald P Danis; Emily Chew

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1528. doi:

ARVO Annual Meeting Abstract September 2016

Feasibility of assessing population prevalence of pathological consequences of myopia in NHANES 2005-2008 data

Susan Vitale; Jeffrey Ryuta Willis

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2480. doi:

ARVO Annual Meeting Abstract September 2016

The Burden of High Myopia and Pathological Myopia in the United States

Jeffrey Ryuta Willis; Susan Vitale; Lawrence S Morse; David W Parke; William L Rich; Flora Lum; Ronald Cantrell

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2467. doi:

ARVO Annual Meeting Abstract September 2016

Validation study for an image-based standardized grading system for scleritis

Maggie M Wei; Jared E Knickelbein; Karen R Armbrust; Denise Cunningham; Susan Vitale; Robert B Nussenblatt; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):3305. doi:

ARVO Annual Meeting Abstract September 2016

Optical Coherence Tomography Minimum Intensity Abnormalities in Hydroxychloroquine Toxicity

Paul F Stetson; Ali M Allahdina; Susan Vitale; Catherine Cukras

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4246. doi:

Clinical and Epidemiologic Research April 2016

Diabetes, Triglyceride Levels, and Other Risk Factors for Glaucoma in the National Health and Nutrition Examination Survey 2005–2008

PDF

Fang Ko; Michael V. Boland; Priya Gupta; Shekhar K. Gadkaree; Susan Vitale; Eliseo Guallar; Di Zhao; David S. Friedman
TAGS: diabetes mellitus, type 2, glaucoma, national health and nutrition examination survey, risk factors, triglycerides
Invest. Ophthalmol. Vis. Sci.. 2016; 57(4):2152-2157. doi: https://doi.org/10.1167/iovs.15-18373

ARVO Annual Meeting Abstract June 2015

Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT) in Uveitis: An Intra-Session and Inter-Observer Reproducibility Study

Jane S. Kim; Laurence Jaworski; Padmini Kaushal; Susan Vitale; Jared E. Knickelbein; Robert B Nussenblatt; H Nida Sen

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):1722. doi:

ARVO Annual Meeting Abstract June 2015

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

Susan Vitale; Traci E Clemons; Elvira Agron; Frederick L Ferris; Amitha Domalpally; Ronald P Danis; Emily Y Chew; AREDS2 Research Group

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3794. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Visual field score decline in eyes with untreated diabetic retinopathy: historical data from the Diabetic Retinopathy Study (DRS) randomized clinical trial

Anti-drug antibodies to monoclonal TNF inhibitors in non-infectious uveitis

Does cataract surgery increase the risk of future development of late AMD? A nested case-control study from the AREDS2 and AREDS2 Follow-On studies

Cataract Surgery and the Risk of Progression to Late Age-Related Macular Degeneration: The Age-Related Eye Disease Study 2

Predictors of poor visual acuity 2 years after initial anti-VEGF therapy in the Age-Related Eye Disease Study 2 (AREDS2)

Hierarchical Cluster Analysis of Serum and Vitreous Cytokines in Intermediate, Posterior and Panuveitis

Repeatability of Optical Coherence Tomography Angiography in Uveitic Eyes

Association of short-term progression in AMD score with risk of development of late AMD and vision loss in the AREDS2 study

IMI – Defining and Classifying Myopia: A Proposed Set of Standards for Clinical and Epidemiologic Studies

Assessing the Variability and Repeatability of OCT-A in Uveitis Patients

Visual acuity outcomes in eyes treated with anti-VEGF injections during the Age-Related Eye Disease Study 2 (AREDS2)

Optical Coherence Tomography Minimum Intensity as an Objective Measure for the Detection of Hydroxychloroquine Toxicity

Assessing the prognostic significance of early changes in AMD scale score in the AREDS study

Feasibility of assessing population prevalence of pathological consequences of myopia in NHANES 2005-2008 data

The Burden of High Myopia and Pathological Myopia in the United States

Validation study for an image-based standardized grading system for scleritis

Optical Coherence Tomography Minimum Intensity Abnormalities in Hydroxychloroquine Toxicity

Diabetes, Triglyceride Levels, and Other Risk Factors for Glaucoma in the National Health and Nutrition Examination Survey 2005–2008

Enhanced Depth Imaging Optical Coherence Tomography (EDI-OCT) in Uveitis: An Intra-Session and Inter-Observer Reproducibility Study

Evaluating the AREDS grading scale for age-related macular degeneration in AREDS2

To View More...

You must be signed into an individual account to use this feature.